Nutex Health Inc. (NUTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

-100M 0 100M 200M 300M Q2 '16: 0 Q3 '16: 0 Q4 '16: -403.8K Q1 '17: 4.3K Q2 '17: 4.6K Q3 '17: 19K Q1 '18: 4.2K Q2 '18: 3.7K Q3 '18: 22.6K Q4 '18: 1.3M Q1 '19: 212.1K Q2 '19: 445.3K Q3 '19: 194.6K Q4 '19: 514.4K Q1 '20: 465.6K Q2 '20: 378.6K Q3 '20: 350K Q4 '20: 272.8M Q1 '21: 2M Q2 '21: 62.8M Q3 '21: 118M Q4 '21: 63.4M Q1 '22: 79.1M Q2 '22: 58M Q3 '22: 28.4M Q4 '22: 53.7M Q1 '23: 56.3M Q2 '23: 58.9M Q3 '23: 62.7M Q4 '23: 69.7M Q1 '24: 67.5M Q2 '24: 76.1M Q3 '24: 78.8M Q4 '24: 257.6M Q1 '25: 211.8M Q2 '25: 244M Q3 '25: 267.8M Q4 '25: 151.7M Q1 '26: 216.5M Q2 '26: 210.8M Q2 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-60M 0 60M 120M 180M Q3 '16: 0 Q4 '16: -400.6K Q1 '17: 4.2K Q2 '17: -9.8K Q3 '17: 11.1K Q4 '17: -12.7K Q1 '18: -3.7K Q2 '18: -4.2K Q3 '18: 14.7K Q4 '18: 852.5K Q1 '19: 43.7K Q2 '19: 118.2K Q3 '19: 111.3K Q4 '19: 262.8K Q1 '20: 266.5K Q2 '20: 113.7K Q3 '20: 139.1K Q4 '20: 157.1M Q1 '21: 426.9K Q2 '21: 29.1M Q3 '21: 76M Q4 '21: 19.5M Q1 '22: 35.8M Q2 '22: 6.6M Q3 '22: -23.7M Q4 '22: 530.3K Q1 '23: 4.8M Q2 '23: 9.6M Q3 '23: 7.1M Q4 '23: 13.2M Q1 '24: 10.2M Q2 '24: 22.6M Q3 '24: 21.9M Q4 '24: 141.6M Q1 '25: 118.3M Q2 '25: 124.9M Q3 '25: 154.9M Q4 '25: 46.1M Q1 '26: 91.7M Q2 '26: 141.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '16: -75.7K Q4 '16: -146.4K Q1 '17: -163.2K Q2 '17: -1.2M Q3 '17: -711.9K Q4 '17: -3.6M Q1 '18: -412K Q2 '18: -489K Q3 '18: -367K Q4 '18: 427.6K Q1 '19: -925.9K Q2 '19: -1.5M Q3 '19: -906.1K Q4 '19: -3.6M Q1 '20: -939.9K Q2 '20: 645.6K Q3 '20: 1.8M Q4 '20: 151.7M Q1 '21: -4.1M Q2 '21: 27.6M Q3 '21: 74.5M Q4 '21: 15.5M Q1 '22: 29.2M Q2 '22: -1.4M Q3 '22: -428.7M Q4 '22: -5.8M Q1 '23: -4.4M Q2 '23: -362.5K Q3 '23: -821.2K Q4 '23: -26.1M Q1 '24: 1.4M Q2 '24: 5.3M Q3 '24: 9.7M Q4 '24: 114.2M Q1 '25: 80.7M Q2 '25: 33.7M Q3 '25: 130.4M Q4 '25: 30.9M Q1 '26: 81.3M Q2 '26: 121.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '16: 216.7K Q4 '16: -7.3M Q1 '17: -242.1K Q2 '17: -1.6M Q3 '17: 6.3M Q4 '17: -3.9M Q1 '18: -610K Q2 '18: -726.2K Q3 '18: -608.5K Q4 '18: 994.7K Q1 '19: -968.2K Q2 '19: -1.6M Q3 '19: -857.6K Q4 '19: -3.7M Q1 '20: -1.1M Q2 '20: 227.3K Q3 '20: 1.8M Q4 '20: 105.1M Q1 '21: -4.5M Q2 '21: 29.7M Q3 '21: 74.5M Q4 '21: 32.9M Q1 '22: 21.4M Q2 '22: -19.3M Q3 '22: -412.2M Q4 '22: -14.8M Q1 '23: -5.1M Q2 '23: -3.5M Q3 '23: -5.5M Q4 '23: -31.6M Q1 '24: -364K Q2 '24: -364K Q3 '24: -8.8M Q4 '24: 61.7M Q1 '25: 21.2M Q2 '25: -17.7M Q3 '25: 55.4M Q4 '25: 11.8M Q1 '26: 46.8M Q2 '26: 65.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

-2M 0 2M 4M 6M Q3 '12: 163.3K Q4 '12: 142.6K Q1 '13: 115.8K Q2 '13: 149.6K Q2 '13: 149.6K Q3 '13: 134K Q4 '13: 96.6K Q1 '14: 102.9K Q2 '14: 123.7K Q2 '14: 123.7K Q3 '14: 115.2K Q4 '14: 123.5K Q1 '15: 135.6K Q2 '15: 167.4K Q3 '15: 125.8K Q1 '16: 3.2K Q2 '16: 0 Q3 '16: 0 Q4 '16: -3.2K Q1 '17: 180 Q2 '17: 14.4K Q3 '17: 8K Q4 '17: 7.9K Q1 '18: 7.9K Q2 '18: 7.9K Q3 '18: 7.8K Q4 '18: 484K Q1 '19: 168.5K Q2 '19: 327.1K Q3 '19: 83.3K Q4 '19: 251.6K Q1 '20: 199.1K Q2 '20: 264.9K Q3 '20: 210.9K Q4 '20: 234.9K Q1 '21: 1.6M Q2 '21: 4.2M Q3 '21: 4.4M Q4 '21: 4.5M Q1 '22: 4.5M Q2 '13 Q2 '14 Q3 '15 Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '22

Operating Cash Flow Quarterly

-40M 0 40M 80M 120M Q2 '16: 58.7K Q3 '16: 23.1K Q4 '16: -73.7K Q1 '17: -124.7K Q2 '17: -243K Q3 '17: -155.9K Q4 '17: -191.1K Q1 '18: -273.2K Q2 '18: -218.8K Q3 '18: -220.7K Q4 '18: -52.7K Q1 '19: -864.8K Q2 '19: -823.8K Q3 '19: -861.8K Q4 '19: -1.5M Q1 '20: -873K Q2 '20: -495.2K Q3 '20: -189.8K Q4 '20: 88.2M Q1 '21: -567.1K Q2 '21: 103.3M Q3 '21: 24.3M Q4 '21: 46.4M Q1 '22: 35.7M Q2 '22: 17.7M Q3 '22: -7.3M Q4 '22: 4.5M Q1 '23: 1.1M Q2 '23: 12.3K Q3 '23: 2M Q1 '24: 3.1M Q2 '24: 13.3M Q3 '24: 6.8M Q4 '24: 54K Q1 '25: 51M Q2 '25: 27.3M Q3 '25: 99.5M Q4 '25: 70.4M Q1 '26: 75.5M Q2 '26: 34.2M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-35M 0 35M 70M 105M Q1 '12: -5.9K Q2 '12: 5.3K Q3 '12: -269K Q4 '12: -257.1K Q1 '14: 849 Q2 '14: 616.1K Q3 '14: -254.2K Q4 '14: -200.1K Q1 '15: -124.9K Q2 '15: -14 Q3 '15: -28.1K Q4 '15: -145.2K Q3 '16: 23.1K Q1 '19: -906.6K Q2 '19: -866.3K Q3 '19: -872.8K Q1 '20: -873K Q2 '20: -495.2K Q3 '20: -189.8K Q4 '20: 27M Q1 '21: -567.1K Q2 '21: 81.6M Q3 '21: 20.8M Q4 '21: 34.7M Q1 '22: 27.1M Q2 '22: 9.6M Q3 '22: -13.2M Q1 '23: -3.3M Q2 '23: -3.1M Q3 '23: -907.2K Q1 '24: 2.3M Q2 '24: 12.7M Q3 '24: 6.2M Q4 '24: -341K Q1 '25: 50.9M Q2 '25: 26.5M Q3 '25: 99.2M Q4 '25: 69M Q1 '26: 74.3M Q2 '26: 31.7M Q1 '14 Q2 '15 Q2 '19 Q4 '20 Q1 '22 Q3 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 250M 500M 750M Q2 '10: 24M Q2 '11: 24M Q1 '13: 25M Q2 '13: 25M Q3 '13: 25M Q1 '14: 25M Q2 '14: 25.4M Q2 '14: 25.4M Q3 '14: 26.7M Q2 '15: 26.9M Q3 '15: 27.8M Q1 '16: 39.7M Q1 '17: 48.8M Q2 '21: 592.8M Q3 '21: 592.8M Q1 '22: 592.8M Q2 '22: 646.4M Q3 '22: 654.8M Q1 '23: 43.4M Q2 '23: 656.6M Q3 '23: 4.4M Q1 '24: 4.8M Q2 '24: 5M Q3 '24: 5.1M Q1 '25: 6.5M Q2 '25: 6M Q3 '25: 7.2M Q1 '26: 7.2M Q2 '26: 7M Q2 '10 Q3 '13 Q3 '14 Q1 '17 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -9.00 0.00 9.00 18.00 27.00 Q1 '13: -0.07 Q2 '13: -0.04 Q1 '15: -0.05 Q2 '15: -0.05 Q3 '15: -0.04 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.19 Q1 '17: -0.18 Q2 '17: -0.21 Q3 '17: -0.15 Q4 '17: 0.01 Q1 '18: 0.00 Q2 '18: 0.02 Q3 '18: -2.13 Q4 '19: -1.97 Q1 '20: -1.83 Q2 '20: -1.34 Q3 '20: -0.78 Q4 '20: -1.17 Q1 '21: -1.17 Q2 '21: -1.17 Q3 '21: -1.42 Q4 '21: -0.08 Q1 '22: 0.20 Q2 '22: 0.12 Q3 '22: -0.59 Q4 '22: -0.63 Q1 '23: -0.79 Q2 '24: -8.87 Q3 '24: -9.34 Q4 '24: 9.25 Q1 '25: 12.66 Q2 '25: 9.78 Q3 '25: 19.26 Q4 '25: 9.75 Q1 '26: 12.94 Q2 '26: 25.27 Q3 '15 Q4 '16 Q1 '18 Q2 '20 Q3 '21 Q4 '22 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.